Micron’s 260% Rally Faces Earnings Test as AI Memory Boom Enters New Phase

Technology

Grail Missed Its Endpoint, But Investors May Have Missed the Real Story

Life Science

What the SpaceX IPO Teaches Investors About the Coming Anthropic and OpenAI Offerings

Technology

VOO vs. RSP: The Hidden Risk in Buffett’s Go-To S&P 500 ETF That Most Investors Miss

Financial Service, Technology

AI Rewrites Drug Discovery: Eli Lilly and Twist Bioscience Chart Two Distinct Industrialization Paths

Life Science, Technology

Nvidia and Intel Rallied Too Much, Broadcom Is the AI Chip Bargain Investors Need

Technology

Why CRISPR Therapeutics Stock Is Stuck Despite Boasting the World’s First Approved CRISPR Therapy

Life Science

Nebius to Join Nasdaq-100 After 1,320% Rally Fueled by Global AI Compute Crunch

Technology

SanDisk’s 5,655% Spinoff Rally: Has the AI Storage Star Yet to Peak?

Technology

S&P 500 Flashes Rare Bullish Signal: After 19% Two-Month Surge, History Says 28% Gain Next

Consumer Goods, Financial Service, Life Science, Technology

Cerebras’s 42% Slump Post-IPO: A Buying Opportunity or a Value Trap?

Technology

At $2.5T, SpaceX Wants to Be the Next Nvidia. Here’s Why It’s Not There Yet

Technology

Citi Bullish on Semiconductor Equipment Leaders as Agentic AI Drives Memory Demand Surge

Technology

Biotech Stocks Surge 61% as CRISPR, Vertex Emerge as Top Picks

Life Science

From Dinosaur to 483% Surge: Is Intel a Golden Opportunity or a Value Trap?

Technology